Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples